MedCap AB (publ)
STO:MCAP

Watchlist Manager
MedCap AB (publ) Logo
MedCap AB (publ)
STO:MCAP
Watchlist
Price: 541 SEK -4.25% Market Closed
Market Cap: 8B SEK
Have any thoughts about
MedCap AB (publ)?
Write Note

MedCap AB (publ)
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MedCap AB (publ)
Revenue Peer Comparison

Comparables:
ALIF B
BICO
BIOT
G
GENO
M
MAGLE

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
MedCap AB (publ)
STO:MCAP
Revenue
kr1.8B
CAGR 3-Years
26%
CAGR 5-Years
20%
CAGR 10-Years
7%
AddLife AB
STO:ALIF B
Revenue
kr9.7B
CAGR 3-Years
22%
CAGR 5-Years
31%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Revenue
kr2.2B
CAGR 3-Years
76%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Revenue
kr2.1B
CAGR 3-Years
21%
CAGR 5-Years
15%
CAGR 10-Years
16%
G
Genovis AB
STO:GENO
Revenue
kr127m
CAGR 3-Years
22%
CAGR 5-Years
24%
CAGR 10-Years
30%
M
Magle Chemoswed Holding AB
STO:MAGLE
Revenue
kr170.4m
CAGR 3-Years
6%
CAGR 5-Years
10%
CAGR 10-Years
N/A

See Also

What is MedCap AB (publ)'s Revenue?
Revenue
1.8B SEK

Based on the financial report for Sep 30, 2024, MedCap AB (publ)'s Revenue amounts to 1.8B SEK.

What is MedCap AB (publ)'s Revenue growth rate?
Revenue CAGR 10Y
7%

Over the last year, the Revenue growth was 23%. The average annual Revenue growth rates for MedCap AB (publ) have been 26% over the past three years , 20% over the past five years , and 7% over the past ten years .

Back to Top